ContextAdherence to antiretroviral therapy is a powerful predictor of survival for individuals
living with human immunodeficiency virus (HIV) and AIDS. Concerns about incomplete …

Following large-scale roll-out of antiretroviral therapy in sub-Saharan Africa, the non-clinical
efficacy of antiretroviral therapy has received little attention. We aimed to systematically …

This meta-analysis synthesizes eighty-four observational studies, conducted across twenty
countries, to determine the mean proportion of people who reported≥ 90% adherence to …

Background. Access to antiretroviral therapy is rapidly expanding in sub-Saharan Africa.
Identifying the predictors of incomplete adherence, virologic failure, and antiviral drug …

Background. A fixed-dose combination of stavudine, lamivudine, and nevirapine is
extensively used as an antiretroviral regimen in developing countries because of its …

Abstract Context: Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
(HIV/AIDS) is one of the world's most challenging pandemics. For treatment with Highly …

Background. The need for a high level of adherence to antiretroviral drugs has remained a
major hurdle to achieving maximal benefit from its use in pregnancy. This study was …

Background. Antiretroviral treatment programs in sub-Saharan Africa have high rates of
early mortality and loss to follow-up. Switching to second-line regimens is often delayed …

Background Ethiopia is one of the most seriously HIV affected countries in Sub-Saharan
Africa. Anemia is a known predictor of disease progression and death among HIV infected …

Both Human Immunodeficiency Virus (HIV) infection and AIDS remain major public health
crises in Nigeria, a country which harbors more people living with HIV/AIDS than any country …